Skip to main content

Table 3 Treatment costs per cycle

From: Cost-effectiveness analysis of azacitidine in the treatment of high-risk myelodysplastic syndromes in Spain

  Azacitidine BSC LDC SDC
MDS treatment on treatment €4,911.24 €1,426.21 €2,671.20 €20,853.08
Pre-medication €0.70 €0 €2.11 €0
Treatment administration €442.40 €0 €380.20 16,344.02
Pharmacology €3,028.14 €0 €48.38 €790.41
Follow-up appointments €238.55 €238.55 €238.55 €0*
Blood/Platelet transfusion €926.07 €1,070.31 €1,754.35 €2,557.71
Concurrent Medication on treatment €37.90 €54.72 €65.86 €87.21
Routine tests on treatment €237.49 €62.63 €181.74 €1.073.74
MDS treatment off treatment €1,627.78 €1,772.02 €2,456.06 €3,259.42
Follow-up appointments €238.55 €238.55 €238.55 €238.55
Blood/Platelet transfusion €926.07 €1,070.31 €1,754.35 €2,557.71
Concurrent Medication off treatment €54.72 €54.72 €54.72 €54.72
Routine tests off treatment €62.63 €62.63 €62.63 €62.63
Annualized Adverse Events BSC €345.81 €345.81 €345.81 €345.81
Treatment administration BSC €0 €0 €0 €0
AML treatment €1,851.86 €1,851.86 €1,851.86 €1,851.86
Follow-up appointments €233.33 €233.33 €233.33 €233.33
Adverse events €345.81 €345.81 €345.81 €345.81
Concurrent Medication €132.18 €132.18 €132.18 €132.18
Blood/Platelet transfusion €1,070.31 €1,070.31 €1,070.31 €1,070.31
Routine tests €70.24 €70.24 €70.24 €70.24
  1. Abbreviations: MDS = myelodysplastic syndrome; AML = acute myeloid leukaemia; BSC = best supportive care; LDC = low dose chemotherapy; SDC = standard dose chemotherapy.
  2. * Include only 1 chemotherapy session.